CAMPION, DANIELA
CAMPION, DANIELA
SCIENZE MEDICHE
Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease
2020-01-01 Paola Ponzo, Martina Rizza, Daniela Campion, Ilaria Giovo, Michele Roma, Felice Rizzi, Alessandra Risso, Gian Paolo Caviglia, Giorgio Maria Saracco, Carlo Alessandria
Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy
2017-01-01 Younes R, Rosso C, Marietti M, Caviglia GP, Nascè A, Campion D, Cantamessa A, Carucci P, Bugianesi E
Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis
2019-01-01 I. Giovo, D. Campion, P. Ponzo, M. Rizzo, G.P. Caviglia, F. Balzola, S. Martini, M. Torrani Cerenzia, G.M. Saracco, C. Alessandria
Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality?
2020-01-01 Daniela Campion, Martina Rizzo, Paola Ponzo, Alessandro Risso, Ilaria Giovo, Felice Rizzi, Michele Roma, Alessandra Risso, Paola Caropreso, Gian Paolo Caviglia, Loredana Colla, Luigi Biancone, Aldo Manca, Giulio Mengozzi, Giorgio Maria Saracco, Carlo Alessandria
Terlipressin vs noradrenalin for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: 1 5-year retrospective analysis
2020-01-01 Ilaria Giovo, Martina Rizzo, Paola Ponzo, Daniela Campion, Michele Roma, Felice Brizzi, Alessandra Risso, Gian Paolo Caviglia, Federico Balzola, Silvia Martini, Maria Torrani Cerenzia, Giorgio Maria Saracco, Carlo Alessandria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease | 2020 | Paola Ponzo, Martina Rizza, Daniela Campion, Ilaria Giovo, Michele Roma, Felice Rizzi, Alessandra Risso, Gian Paolo Caviglia, Giorgio Maria Saracco, Carlo Alessandria | |
| Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy | 2017 | Younes R, Rosso C, Marietti M, Caviglia GP, Nascè A, Campion D, Cantamessa A, Carucci P, Bugianesi E | |
| Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis | 2019 | I. Giovo, D. Campion, P. Ponzo, M. Rizzo, G.P. Caviglia, F. Balzola, S. Martini, M. Torrani Cerenzia, G.M. Saracco, C. Alessandria | |
| Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality? | 2020 | Daniela Campion, Martina Rizzo, Paola Ponzo, Alessandro Risso, Ilaria Giovo, Felice Rizzi, Michele Roma, Alessandra Risso, Paola Caropreso, Gian Paolo Caviglia, Loredana Colla, Luigi Biancone, Aldo Manca, Giulio Mengozzi, Giorgio Maria Saracco, Carlo Alessandria | |
| Terlipressin vs noradrenalin for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: 1 5-year retrospective analysis | 2020 | Ilaria Giovo, Martina Rizzo, Paola Ponzo, Daniela Campion, Michele Roma, Felice Brizzi, Alessandra Risso, Gian Paolo Caviglia, Federico Balzola, Silvia Martini, Maria Torrani Cerenzia, Giorgio Maria Saracco, Carlo Alessandria |